News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Merck KGaA Seeks FDA Approval for First MS Pill
September 30, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Germany's Merck KGaA filed for approval of its multiple sclerosis (MS) pill cladribine in the United States in a bid to bring the first oral treatment against the debilitating disease to market.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Europe
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Approvals
KalVista Wins OK for First On-Demand Hereditary Angioedema Pill
July 7, 2025
·
2 min read
·
Tristan Manalac
Layoffs
HHS Cuts and Rehires by the Numbers: What We Know About Kennedy’s Overhaul
July 7, 2025
·
3 min read
·
Tristan Manalac
RSV
Kennedy Follows RSV Recommendations of ACIP Members He Fired
July 3, 2025
·
3 min read
·
Tristan Manalac
Accelerated approval
Regeneron Scores Multiple Myeloma Nod for Bispecific, Unlocking $600M Opportunity
July 3, 2025
·
2 min read
·
Tristan Manalac
